Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4

Direct-acting antiviral drugs to cure infections with Hepatitis C virus (HCV) achieve a sustained virological response (SVR) in more than 90% of adult patients. At present, clinical trials are ongoing and real-life data are still limited in children. Herein, we report two cases of pediatric patients...

Full description

Bibliographic Details
Main Authors: Nadia Marascio, Maria Mazzitelli, Grazia Pavia, Aida Giancotti, Giorgio Settimo Barreca, Chiara Costa, Vincenzo Pisani, Giuseppe Greco, Francesca Serapide, Enrico Maria Trecarichi, Francesco Casalinuovo, Maria Carla Liberto, Giovanni Matera, Carlo Torti
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cells
Subjects:
pediatric patients
Hepatitis C virus 4
sofosbuvir/ledipasvir
Online Access:https://www.mdpi.com/2073-4409/8/5/416

Internet

https://www.mdpi.com/2073-4409/8/5/416

Similar Items